Sandy Yeo

Sandy Yeo is a Director of Interface Management in Medical Governance at Bayer Pharmaceuticals, specializing in clinical research and development, medical marketing, audit and compliance, and regulatory approval and labeling. Sandy has led teams in various roles, including Real World Evidence Strategy Lead for both mature brands and the Asia-Pacific region at Bayer, and previously served as Head of Medical Governance and Excellence at Bayer HealthCare. Sandy's background includes a medical degree from the University of Sydney and an MBA from Saïd Business School, University of Oxford. Prior to working at Bayer, Sandy held positions at Abbott Diagnostics, Lilly-NUS Centre for Clinical Pharmacology, and Raffles Medical.